microplasmin

Related by string. Microplasmin * * microplasmin Phase III *

Related by context. All words. (Click for frequent words.) 67 Microplasmin 66 diabetic macular edema DME 66 Phase 2a 66 phase IIa clinical 64 ZYBRESTAT 64 diabetic macular edema 64 vidofludimus 63 CR# vcMMAE 63 Zerenex 63 elagolix 63 OZURDEX ® 63 IMA# 63 EVIZON 63 forodesine 62 talactoferrin 62 riociguat 62 Phase 2b study 62 phase IIa 62 brivaracetam 62 herpetic keratitis 62 RSD# oral 62 CA4P 62 rhC1INH 62 TG# [003] 62 iclaprim 62 BCX# 62 NP2 Enkephalin 62 VA# [002] 62 teriflunomide 62 lomitapide 61 Adlea 61 TRO# 61 Diabetic Macular Edema DME 61 Medidur FA 61 GALNS 61 T Pred 61 ELACYT 61 Phase 2b clinical 61 obatoclax 61 CIMZIA ™ 61 JAK inhibitor 61 Phase 2a clinical 61 phase IIb clinical 61 Phase Ib study 61 oral prodrug 61 Proxinium TM 61 Medidur 61 Phase Ib clinical 61 BEMA TM Fentanyl 61 HCV protease inhibitor 61 OMS# 61 SNT MC# 61 Azedra 61 DDP# 61 oral ridaforolimus 61 INT# [002] 61 ISIS # 61 BAY #-# 61 delivers fluocinolone acetonide FA 61 metaglidasen 61 HuMax EGFr 61 Catena ® 61 eltrombopag 61 Phase 2a trial 60 OMNARIS HFA 60 IRX 2 60 Firazyr 60 vitreomacular adhesion 60 Phase Ib 60 Phase IIa trial 60 ruboxistaurin 60 NEBIDO 60 atacicept 60 alvimopan 60 blepharitis 60 Phase IIIb clinical 60 eculizumab 60 ProSavin 60 refractory gout 60 Retisert TM 60 acetonide FA 60 phase IIb 60 Ozurdex 60 iSONEP 60 Phase IIa trials 60 opioid induced bowel dysfunction 60 GAMMAGARD 60 huC# DM4 60 EOquin TM 60 oral FTY# 60 MEND CABG 60 EchoCRT 60 TG# [001] 60 Phase IIB 60 Bronchitol 60 RhuDex ® 60 phase 2a 60 catheter occlusion 60 Vascugel 59 TG MV 59 OncoVEX GM CSF 59 Archexin 59 PROMACTA 59 Diabetic Macular Edema 59 cangrelor 59 PRT# 59 LEVADEX 59 Exherin TM 59 rNAPc2 59 Dacogen injection 59 BrachySil TM 59 refractory angina 59 EndoTAG TM -1 59 ocular formulation 59 eprotirome 59 Phase IIa clinical 59 pivotal Phase III 59 MAP# 59 Phase 1b 59 tanespimycin 59 OHR/AVR# 59 Phase 2b trial 59 vitreomacular traction 59 vandetanib 59 fluocinolone acetonide 59 axitinib 59 sunitinib malate 59 ecabet sodium 59 PS# [001] 59 LEUKINE 59 deforolimus 59 PXD# 59 Cloretazine R VNP#M 59 TACI Ig 59 elotuzumab 59 ATL/TV# 59 Iluvien 59 Ophena TM 59 INCB# [002] 59 DOR# 59 Retisert 59 tezampanel 59 NGX# 59 Triolex 59 ADVANCE PD 59 Locteron ® 59 L BLP# 59 Iluvien ® 59 EndoBarrier 59 denufosol 59 enzastaurin 59 Phase 2b 59 Alpharadin 59 Phase 1b clinical 59 Prolacria 59 alvespimycin 59 incyclinide 59 Augment Injectable 59 cediranib 59 XmAb# 59 ILUVIEN ® 59 Zelrix 58 posaconazole 58 registrational 58 CIMZIA TM 58 Sym# 58 Phase III clinical 58 cannabinor 58 Mipomersen 58 Aclidinium 58 Bicifadine 58 glufosfamide 58 refractory CLL 58 vascular disrupting agent 58 postoperative ileus POI 58 RG# [001] 58 methylnaltrexone 58 pradefovir 58 Fibrillex TM 58 regorafenib 58 placebo controlled Phase 58 CRLX# 58 CRMD# 58 macular edema 58 tafamidis 58 Phase IIb clinical 58 Phase 1b trial 58 pertuzumab 58 Anturol 58 anticancer compound 58 Anturol ® 58 oral rivaroxaban 58 Tyrima 58 rhThrombin 58 histone deacetylase HDAC inhibitor 58 Phenoptin 58 ofatumumab 58 Trofex 58 octreotide 58 edoxaban 58 velafermin 58 GOUT 58 reslizumab 58 Ostarine 58 Isolagen Therapy 58 TH# [003] 58 thrombolytic agent 58 phase IIb trial 58 dextofisopam 58 Onrigin 58 YONDELIS 58 Icatibant 58 Aurexis 58 Stedivaze 58 Dyloject TM 58 octreotide implant 58 phase IIb study 58 Androxal TM 58 ALN VSP 58 sapropterin dihydrochloride Tablets 58 HspE7 58 Ventavis 58 targeted radiotherapeutic 58 photocoagulation 58 acyclovir Lauriad ® 58 CRx 58 Octreolin 58 AMR# 58 tolevamer 58 Shigamabs ® 58 liprotamase 58 teduglutide 58 APTIVUS 58 Factor VIIa 58 Phase IIb 58 STRIDE PD 58 Alocrest 58 ATL# [001] 58 Vandetanib 58 superficial bladder cancer 58 PRECiSE 58 AEG# 58 ganetespib 58 intravitreal injection 58 DR Cysteamine 58 Civacir 58 PEG SN# 58 trodusquemine 58 MACUGEN 58 LibiGel ® 58 velafermin belinostat 58 keloid scarring 57 mertansine 57 MAA submission 57 ACTEMRA 57 Orazol 57 cilengitide 57 AzaSite Plus 57 iroxanadine 57 HZT 57 aclidinium 57 AZILECT ® 57 luliconazole 57 Vernakalant 57 nalbuphine ER 57 diabetic neuropathic pain 57 Telatinib 57 LymphoStat B 57 Phase IIb trial 57 pomalidomide 57 Phase 2b clinical trials 57 Phase IIa 57 RSD# 57 M6G 57 rilonacept 57 squalamine 57 Elagolix 57 Locteron 57 ABSORB trial 57 Tesetaxel 57 fenretinide 57 lumiliximab 57 Traficet EN 57 postoperative ileus 57 tasocitinib 57 MYDICAR 57 recurrent glioblastoma 57 confirmatory Phase III 57 lucinactant 57 metastatic HRPC 57 Fodosine 57 prucalopride 57 Golimumab 57 Omigard 57 Ceflatonin 57 triamcinolone 57 anterior uveitis 57 Plicera 57 Dapagliflozin 57 ularitide 57 Bezielle 57 DU #b 57 arterial thrombosis 57 hylan GF 57 CCX# 57 Fibrin Pad 57 Rezular 57 GRN# 57 Zybrestat 57 Pirfenidone 57 prospective randomized controlled 57 SCH # 57 BRIM2 57 VEGF Trap 57 Amplimexon 57 MOZOBIL 57 Keppra R 57 FOLOTYN ® 57 Phase IIb trials 57 ZACTIMA 57 placebo controlled clinical 57 oritavancin 57 VAPRISOL 57 esophageal candidiasis 57 interferon beta 1b 57 ranibizumab 57 LUVENIQ 57 HQK 57 ZD# [001] 57 Frova ® 57 MEK inhibitor RDEA# 57 BrachySil 57 Fx #A 57 Phase Ib clinical trials 57 rFVIIa 57 CEQ# 57 neovascular AMD 57 omega interferon 57 AZX# 57 ESBA# 57 dirucotide 57 APEX PD 57 BAL# [002] 57 neratinib 57 GEM OS2 57 ocular hypertension 57 acyclovir Lauriad R 57 recurrent herpes labialis 57 pharmacokinetic PK 57 Cotara 57 randomized Phase IIb 57 NVA# 57 efficacy endpoint 57 Aflibercept 57 Pivotal Phase III 57 omacetaxine mepesuccinate 57 rEV# 57 PDE4 inhibitor 57 dermaPACE 57 neovascular 57 ocrelizumab 57 INC# 57 Celacade TM technology 57 Virulizin R 56 active comparator 56 miconazole Lauriad ® 56 INCB# [001] 56 PREOS R 56 varespladib 56 Restanza 56 cetrorelix 56 CaPre TM 56 CYCLOSET 56 oral formulation 56 bromfenac 56 Juvista 56 CoFactor 56 retinal vein occlusion 56 tiapamil 56 Lixivaptan 56 nab paclitaxel 56 preclinical efficacy 56 MoxDuo IR 56 Azixa 56 diarrhea predominant irritable 56 voclosporin 56 Pemetrexed 56 Cleviprex TM clevidipine 56 optimal dosing regimens 56 severe gastroparesis 56 Ketotransdel 56 darapladib 56 retinal vein occlusion RVO 56 CINTREDEKIN BESUDOTOX 56 pharmacokinetic PK study 56 Bendavia 56 trastuzumab DM1 T DM1 56 TORISEL 56 aflibercept VEGF Trap 56 invasive candidiasis 56 Bepreve 56 Chrysalin 56 SUTENT ® 56 Bob Butchofsky President 56 GW# [003] 56 thymalfasin 56 PREOS 56 Urocortin 2 56 Lung Rx 56 KRN# 56 Leber Hereditary Optic Neuropathy 56 Viramidine 56 canakinumab 56 bimatoprost 56 Phase Ia 56 Oxypurinol 56 TBC# 56 Proellex TM 56 ARIKACE 56 BIBW 56 Androxal 56 PDX pralatrexate 56 fidaxomicin 56 pseudobulbar affect PBA 56 budesonide foam 56 Nexavar ® 56 CINQUIL 56 QNEXA 56 ALVESCO HFA 56 volociximab 56 celgosivir 56 Phase 1a 56 BENLYSTA ® 56 Desmoteplase 56 rALLy clinical trial 56 Ceflatonin R 56 palifosfamide 56 Relovair 56 Rebif ® 56 REMURA 56 Phase III pivotal 56 icatibant 56 tolerability profile 56 Phase #/#a 56 PRX # 56 CIMZIA TM certolizumab pegol 56 brimonidine 56 resminostat 56 Shigamabs R 56 QuadraSphere 56 TASQ 56 Virulizin ® 56 labial herpes 56 pegaptanib 56 virus HCV protease inhibitor 56 European Sepsis Trial 56 SANVAR 56 6R BH4 56 Anturol TM 56 picoplatin 56 lasofoxifene 56 LEVADEX ™ 56 sitaxsentan 56 glycopyrrolate 56 elacytarabine 56 OMAPRO 56 clevidipine 56 otelixizumab 56 cancer immunotherapies 56 bosentan 56 tezampanel NGX# 56 noninfectious uveitis 56 topical formulation 56 Loramyc ® 56 BRIM3 56 BST CarGel R 56 Amrubicin 56 Silodosin 56 olopatadine 56 neovascular diseases 56 StemEx R 56 OncoVEX 56 CYT# potent vascular disrupting 56 Azedra TM 56 arzoxifene 56 angiographic outcomes 56 CRVO 56 PHX# 56 azelastine 56 dalbavancin 56 LymphoStat B belimumab 56 Onalta 56 IMGN# 56 SinuNase 56 goserelin 56 MIVI III 56 menadione 56 torezolid phosphate 56 Amphotericin B 56 multicenter Phase II 56 RDEA# 56 daclizumab 56 Factor Xa inhibitor 56 TOLAMBA 56 Vicinium TM 56 ocular inflammation 56 Myocet 56 PRIMO CABG 56 Aplidin 56 ponatinib 56 investigational pan BCR 56 Cimzia ® 56 Hedgehog antagonist 56 MIRCERA 55 interferon gamma 1b 55 mixed dyslipidemia 55 preclinically 55 AA Amyloidosis 55 faropenem 55 hoFH 55 Rhucin ® 55 aflibercept 55 PTK ZK 55 PENNSAID 55 Alvesco R 55 naproxcinod 55 MKC# MKC# PP 55 Empatic 55 ATryn R 55 Capesaris 55 CRD5 55 BioSTAR R 55 GEM OS1 55 tocilizumab 55 Phase IIb clinical trials 55 Lymphoseek ® 55 ThGRF 55 oxypurinol 55 Macugen 55 LUMINATE 55 romidepsin 55 Veronate 55 BLA filing 55 subcutaneous formulation 55 TriRima 55 SinuNase TM 55 Carfilzomib 55 Tavocept 55 bicifadine 55 ADAGIO study 55 unique alkylating agent 55 Gabapentin GR 55 Nanobody 55 Elocalcitol 55 ozarelix 55 NATRECOR ® 55 INTEGRILIN 55 receptor tyrosine kinase inhibitor 55 Topical Interferon Alpha 2b 55 Pimavanserin 55 FASLODEX 55 Genz # 55 INCB# [003] 55 diabetic peripheral neuropathy 55 NUVIGIL 55 cobiprostone 55 Diamyd ® 55 Chemophase 55 HGS ETR1 55 Cimzia ® certolizumab pegol 55 OvaRex ® MAb 55 angiogenesis inhibitor 55 Viprinex 55 Apixaban 55 neurogenic orthostatic hypotension 55 Zirgan 55 ALA PDT 55 KAMRA inlay 55 urocortin 2 55 febuxostat 55 Probuphine 55 delayed CINV 55 pazopanib 55 NOXAFIL 55 TASKi2 55 Onalta ™ 55 pegaptanib sodium 55 sorafenib tablets 55 UPLYSO 55 induced macular edema 55 AzaSite TM 55 macular hole 55 Nasulin 55 ZOLINZA 55 R#/MEM # 55 cetuximab Erbitux 55 Zenvia ™ 55 Urocidin 55 Diamyd R 55 JAK1 55 ataluren 55 amrubicin 55 ACTEMRA TM 55 zalutumumab 55 JAK2 inhibitor 55 ancrod 55 EVIZON TM squalamine lactate 55 Onbrez Breezhaler 55 ALGRX 55 MGd 55 Loramyc R 55 Phase III 55 SUCCEED trial 55 ibandronate 55 carfilzomib 55 AP# [003] 55 ostarine 55 BLA submission 55 APTIVUS r 55 MEK inhibitor 55 refractory AML 55 ASA# 55 PLX PAD 55 NeuroStar TMS Therapy 55 confirmatory Phase 3 55 malignant ascites 55 Emselex 55 pharmacodynamic effects 55 bevacizumab Avastin 55 HepeX B 55 choroidal neovascularization 55 Cimzia TM 55 bacterial conjunctivitis 55 SonoLysis 55 LEVADEX TM 55 dermaPACE ™ 55 IMPACT DCM clinical 55 Phase III trials 55 phase IIIb 55 SARMs 55 Phase III Pivotal 55 HuMax CD# 55 double blinded placebo 55 Benign Prostatic Hyperplasia BPH 55 prokinetic agent 55 Imprime PGG 55 ranibizumab Lucentis 55 DACH platinum 55 CIPN 55 Xanafide 55 COSIRA trial 55 Epanova 55 TPI ASM8 55 LHRH antagonists 55 CytoFabTM 55 zanolimumab 55 Dupuytren Contracture 55 Onconase 55 APF# 55 PEG Interferon lambda 55 Squalamine 55 EOquin 55 ocular allergies 55 vernakalant 55 Nexavar sorafenib 55 leading oral taxane 55 Tracleer R 55 Viprinex TM 55 nosocomial pneumonia 55 OPAXIO 55 initiate Phase 1b 55 OXi# 55 ThermoDox 55 metastatic hormone refractory 55 severe hypercholesterolemia 55 IIa trial 55 diabetic nephropathy 55 Torisel 55 SILENOR 55 ACV1 55 TMC# [002] 55 olaparib 55 CUSTOM III 55 trabedersen 55 occlusion CRVO 55 Indaflex TM 55 bevasiranib 55 faropenem medoxomil 55 CDP# 55 AeroLEF TM 55 SUPPRELIN R LA 55 Lu AA# 55 Xibrom 55 Zingo TM 55 MAGE A3 ASCI 55 ALN TTR# 55 EVICEL 55 eniluracil 55 viral kinetic 55 Arcalyst 55 BYDUREON 55 TroVax 55 thetreatment 55 safinamide 55 Neovascular AMD 55 Panzem R NCD 55 KNS # 55 PSN# [002] 55 iniparib 55 velaglucerase alfa 55 Cellegesic 55 REOPRO 55 Luveniq 55 dose escalation trial 55 Phase 1a clinical 55 glucokinase activator 54 elevated intraocular pressure 54 vitreous hemorrhage 54 PROSTVAC TM 54 Phase #b/#a trial 54 Phase IIIb 54 PGL# 54 multicenter Phase III 54 pivotal Phase 54 Insegia 54 humanized monoclonal antibody 54 cortical stimulation 54 Tanespimycin 54 topical diclofenac 54 retinal disorders 54 oxymorphone ER 54 Ozarelix 54 Efficacy Results 54 Raptiva ® 54 Alfimeprase 54 dose escalation clinical 54 urethral bulking agent 54 Phase #/#a trial 54 orBec 54 Evoltra TM 54 Alzhemed TM 54 selective androgen receptor modulator 54 ONCONASE 54 GLP toxicology studies 54 regadenoson 54 Aurora kinase inhibitor 54 PEG PAL 54 acute peripheral arterial 54 alfimeprase 54 oral mucositis 54 PAOD 54 DXL# 54 randomized Phase III 54 Phase #b/#a 54 Atiprimod 54 lixisenatide 54 Technosphere Insulin 54 EP #R 54 HuLuc# 54 Firdapse 54 oral methylnaltrexone 54 acute coronary syndromes ACS 54 Hsp# inhibitor 54 including eniluracil ADH 54 thorough QT 54 dimebon 54 post herpetic neuralgia 54 Mepact 54 liposomal formulation 54 oral anticoagulant 54 ProLindac 54 HCV SPRINT 54 sargramostim 54 BLP# Liposome Vaccine 54 Reolysin 54 intravitreal triamcinolone 54 ISTODAX 54 TroVax ® 54 endophthalmitis 54 relapsed multiple myeloma 54 ILLUMINATE 54 synthetic retinoid 54 geographic atrophy 54 Troxatyl 54 fenofibric acid 54 ACAPODENE 54 EFAPROXYN 54 thrombolytic agents 54 lorvotuzumab mertansine 54 Arikace 54 Ranibizumab 54 LUX Lung 54 XIENCE V stent 54 Ophena 54 ARCOXIA 54 dexanabinol 54 PERLANE 54 analgesic efficacy 54 ACOMPLIA R 54 LibiGel Phase III 54 QLT# 54 SILENOR TM 54 rindopepimut 54 linaclotide 54 ITAX 54 ophthalmic indications 54 Flutiform TM 54 INS# [001] 54 PEG uricase 54 Novolimus 54 prospective multicenter 54 Amigal 54 Pennsaid R 54 PRECISE 54 Soliris eculizumab 54 investigational compound 54 EDEMA3 54 laquinimod 54 LE SN# 54 TLK# 54 Bepreve TM 54 Degarelix 54 Phase III Clinical Trial 54 ARCALYST ® 54 GLPG# 54 EGS# 54 Celacade TM 54 docetaxel Taxotere ® 54 Glypromate 54 LY# [003] 54 vicriviroc 54 bazedoxifene 54 Rescula 54 sNDA submission 54 BRAF inhibitor 54 TELCYTA 54 pegloticase 54 Cetrorelix 54 bardoxolone 54 roflumilast 54 SRT# [003] 54 carcinoid syndrome 54 TMS Therapy 54 PEP# [003] 54 Huntexil 54 fostamatinib 54 ritonavir boosted danoprevir 54 MabCampath 54 rALLy 54 sodium thiosulfate STS 54 Octreotide 54 ruxolitinib 54 Abbokinase 54 MYCAMINE 54 Medidur TM FA 54 Entereg R 54 HCV RESPOND 2 54 triamcinolone acetonide 54 etanercept Enbrel 54 VEGF inhibitor 54 Phase Ib II 54 collagen crosslinking 54 HuMax CD4 54 Targretin 54 Kuvan R 54 triphendiol 54 EDEMA4 54 Clolar ® 54 ICA # 54 perifosine 54 diquafosol 54 investigational humanized monoclonal antibody 54 evaluable patients 54 ongoing Phase 1b 54 masked placebo controlled 54 Mycograb 54 tesamorelin 54 Resten NG 54 atrasentan 54 ecallantide 54 Cloretazine ® 54 pharmacodynamic 54 multicenter Phase 54 salmeterol fluticasone 54 TASKi3 54 Panzem 54 tesofensine 54 miconazole Lauriad R 54 tecarfarin 54 OncoGel 54 afamelanotide 54 Perifosine 54 renal anemia 54 anidulafungin 54 investigational hepatitis C 54 FOLOTYN 54 CAPHOSOL 54 Aviptadil 54 terlipressin 54 Lucentis ranibizumab 54 elesclomol 54 telavancin 54 HoFH 54 lurasidone 54 cardio renal 54 novel histone deacetylase 54 Noxafil 54 fosbretabulin 54 oral diclofenac 54 TMC# C# 54 FTY# 54 mipomersen 54 Phase #b/#a clinical 54 EXPAREL ™ 54 DEB# 54 Abiraterone acetate 54 Dasatinib 54 aclidinium bromide 54 Intravitreal injections 54 AGGRASTAT R 54 AZILECT R 54 latanoprost 54 administered topically 54 dronedarone 54 ADX# 54 LB# [003] 54 metastatic neuroendocrine tumors 54 Plenaxis TM 54 timolol 54 phase IIb III 54 Evoltra 54 amifampridine phosphate 54 Iluvien TM 54 investigational antiplatelet agent 54 randomized Phase 54 TYZEKA 54 dose escalation Phase 54 oral picoplatin 54 retinal vein occlusion induced 54 DYNEPO 54 Daclizumab 54 trastuzumab emtansine T DM1 54 custirsen 54 antibody MAb 54 tivozanib 54 sorafenib Nexavar 54 TAXUS Liberte stent 54 VFEND 54 baminercept 54 QNEXA ® 53 BROVANA 53 PRE SURGE 53 vertebral compression fractures 53 SANCTURA XR 53 prospective multicenter study 53 Hsp# Inhibitor 53 pralatrexate 53 Cethromycin 53 PD LID 53 macular holes 53 placebo controlled Phase III 53 Central Retinal Vein 53 Onychomycosis 53 prospective multicenter randomized 53 Dyloject 53 macular edema secondary 53 adecatumumab 53 Pafuramidine 53 Santhera 53 blinatumomab 53 Acute Ischemic Stroke 53 Ketotransdel TM 53 Lovaxin C 53 somatostatin analogue 53 relapsed refractory multiple myeloma 53 Tamibarotene 53 multicentre randomized 53 ALD# 53 Muraglitazar 53 INVEGA ® 53 Rhucin R 53 AGGRASTAT ® 53 ThermoDox ® 53 SPIRIT FIRST 53 drug eluting stent DES 53 candidate Zenvia 53 2 methoxyestradiol 53 REMINYL ® 53 SUTENT 53 Soliris TM eculizumab 53 nitazoxanide 53 talabostat 53 Aldara Cream 53 NATRECOR R 53 DexaSite 53 CYT# 53 Pivotal Phase 53 LHON 53 Actemra tocilizumab

Back to home page